YOUNG INVESTIGATOR POSTER PRESENTATIONS
Dr. Solomon Abate
Real World Population-Based Outcome Analysis
of Small Lymphocytic Lympoma (SSL)
in British Columbia (BC)
Dr. Alex Kwan
Healthcare Resource Utilization with Prophylactic IV
Anakinra Following Anti-CD19 CAR T-cell Therapy in B-cell Lymphoma:
A Canadian Single-Centre Quality Improvement Experience
Dr. Rafal Asmaro
Treatment and Outcomes of Accelerated Chronic
Lymphocytic Leukemia Small Lymphocytic Lymphoma
in the Targeted Therapy Era
Dr. Linda Guo
High Incidence of Cutaneous Injection Site Reactions
with Subcutaneous Rituximab in Hairy Cell Leukemia
A Provincial Retrospective Cohort Study
Dr. Agnes Ho
Real World Outcomes and Healthcare
Utilization with CD20xCD3 Bispecific Antibodies
for Relapsed Refractory DLBCL
Dr. Asim Ibrahim
Associations between Mitochondrial
Respiration and Clinical Prognostic Markers in
Chronic Lymphocytic Leukemia (CLL)
Dr. Jonathan Isenberg
Outcomes Of Patients Treated With Isatuximab
Based Regimens For Relapsed Refractory
Multiple Myeloma From British Columbia
Dr. Keith Lau
High-dose methotrexate, rituximab,
and temozolomide as first-line therapy
of primary CNS lymphoma
Dr. Thomas Lowe
Clinical Significance and Management of
Positive End of Treatment PET Scans in
Diffuse Large B-cell Lymphoma
Dr. Caroline Spanner
EBV-Driven Lymphoproliferative B Cell
Malignancies after BiTE-Treatment for
Refractory Multiple Myeloma
1
Dr. Joshua Yi
Radiotherapy Consolidation Post-Autologous Stem Cell Transplant
in Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Improves
Progression-Free and Overall Survival in Patients with
Partial but Not Complete Metabolic Response Pre-Transplant
